This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Singapore warns of state-linked cyber assault on critical infrastructure

( July 19, 2025, 08:30 GMT | Official Statement) -- MLex Summary: Singapore is facing a sharp escalation in state-linked cyber threats, with authorities warning that sophisticated actors are targeting the country’s most critical systems. In a speech marking the Cyber Security Agency’s 10th anniversary, Home Affairs and National Security Minister K. Shanmugam revealed that suspected Advanced Persistent Threat attacks have more than quadrupled since 2021 and that the notorious UNC3886 group is currently striking key infrastructure. He said the attackers — likely linked to foreign governments — have previously breached universities, healthcare data and even household devices, forming botnets capable of disrupting essential services. The latest intrusion, now under active containment, was described as serious, though officials withheld details for security reasons.The speech excerpt follows: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections